Role of the kidney in human leptin metabolism.

To assess the role of the human kidney in leptin metabolism, we measured renal leptin net balance and urinary leptin excretion in 16 normal postabsorptive volunteers with varying degrees of obesity. Arterial leptin concentrations (11.6 ± 2.7 ng/ml) significantly exceeded renal vein concentrations (10.3 ± 2.5 ng/ml, P < 0.001). Renal leptin fractional extraction averaged 13.1 ± 1.1%, and renal leptin net balance (uptake) averaged 1,070 ± 253 ng/min. Lineweaver-Burk analysis indicated that renal leptin uptake followed saturation kinetics with an apparent Michaelis-Menten constant of 10.9 ng/ml and maximal velocity of 1,730 ng/min. Leptin was generally undetectable in urine. Using literature values for systemic leptin clearance, we calculated that renal leptin uptake could account for ∼80% of all leptin removal from plasma. These data indicate that the human kidney plays a substantial role in leptin removal from plasma by taking up and degrading the peptide.

[1]  H. Baum,et al.  Leptin is cleared from the circulation primarily by the kidney. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[2]  N. Laird,et al.  Assessment of nutritional status of the National Cooperative Dialysis Study population. , 1983, Kidney international. Supplement.

[3]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[4]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[5]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[6]  S. Klein,et al.  Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. , 1996, The Journal of clinical endocrinology and metabolism.

[7]  G. Coles.  Body composition in chronic renal failure. , 1972, The Quarterly journal of medicine.

[8]  S. Klein,et al.  Radioimmunoassay of leptin in human plasma. , 1996, Clinical chemistry.

[9]  K. Nakao,et al.  Human Obese Gene Expression: Adipocyte-Specific Expression and Regional Differences in the Adipose Tissue , 1995, Diabetes.

[10]  C. Brun.  A rapid method for the determination of para-aminohippuric acid in kidney function tests. , 1951, The Journal of laboratory and clinical medicine.

[11]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[12]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[13]  P. Kurtin,et al.  Volume status and body composition of chronic dialysis patients: utility of bioelectric impedance plethysmography. , 1990, American journal of nephrology.

[14]  S. Coppack,et al.  Adipose Tissue Leptin Production and Plasma Leptin Kinetics in Humans , 1996, Diabetes.

[15]  D. Wilmore,et al.  The heated dorsal hand vein: an alternative arterial sampling site. , 1989, JPEN. Journal of parenteral and enteral nutrition.

[16]  R. Berliner,et al.  A Simplified Clinical Procedure for Measurement of Glomerular Filtration Rate and Renal Plasma Flow.∗ , 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  S. Klein,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Increased Plasma Leptin Concentration in End-Stage Renal Disease* , 2022 .

[18]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[19]  R. Rabkin,et al.  Renal metabolism of peptide hormones. , 1983, Mineral and electrolyte metabolism.

[20]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.